Iovance Biotherapeutics Inc (IOVA)
10.24
-0.19
(-1.82%)
USD |
NASDAQ |
May 17, 16:00
10.15
-0.09
(-0.88%)
After-Hours: 20:00
Iovance Biotherapeutics Gross Profit Margin (Quarterly): -915.5% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -915.5% |
December 31, 2023 | -805.6% |
Date | Value |
---|---|
September 30, 2023 | -825.4% |
June 30, 2023 | -761.3% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-915.5%
Minimum
Mar 2024
-761.3%
Maximum
Jun 2023
-827.0%
Average
-815.5%
Median
Gross Profit Margin (Quarterly) Benchmarks
Viatris Inc | 41.05% |
Perspective Therapeutics Inc | -- |
Electromed Inc | 74.85% |
Xtant Medical Holdings Inc | 62.07% |
Asensus Surgical Inc | -172.1% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -70.61% |
Return on Assets | -55.17% |
Return on Invested Capital | -71.34% |
Profit Margin (Quarterly) | -15.80K% |
Operating Margin (Quarterly) | -16.46K% |
Return on Net Operating Assets | -102.8% |